{"groups":[{"description":"Paclitaxel 175 mg/m2 IV over 3 hours followed by Carboplatin AUC = 6 IV over 30 minutes repeated every 21 days until disease progression or adverse effects prohibit further therapy","id":"FG000","title":"Paclitaxel Followed by Carboplatin"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"8"}],"type":"Refused further treatment"},{"reasons":[{"groupId":"FG000","numSubjects":"12"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"9"}],"type":"Other, Not Specified"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Patient never treated"},{"reasons":[{"groupId":"FG000","numSubjects":"7"}],"type":"Ineligible"}],"milestones":[{"achievements":[{"comment":"All patients enrolled on study","groupId":"FG000","numSubjects":"55"}],"type":"STARTED"},{"achievements":[{"comment":"Completed regimen due to progression","groupId":"FG000","numSubjects":"15"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"40"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}